Q3 2025 Management View CEO Horacio Rozanski highlighted strong financial results for Q3 with double-digit growth in both revenue and earnings. He emphasized the strategic and operational momentum ...

MACOM Technology Solutions Holdings, Inc. ( NASDAQ: MTSI) Q1 2025 Earnings Conference Call February 6, 2025 8:30 AM ET Steve Ferranti - VP of Corporate Development and IR Steve Daly - President and ...

Q1 2025 Earnings Call Transcript February 6, 2025 MACOM Technology Solutions Holdings, Inc. beats earnings expectations. Reported EPS is $0.79, expectations were $0.78. Operator: Welcome to MACOM’s ...

President Donald Trump and his administration have made a variety of complaints about Canada to justify his plan to impose 25% tariffs on most imports from Canada (with 10% tariffs on energy imports) ...

The Department of Defense is making a bold investment in the future, dedicating $139.9 million to its Chief Digital and Artificial Intelligence Office for fiscal year 2025. This funding signals a ...

Employees of the Defense Intelligence Agency and National Security Agency are among government workers being offered buyouts as the Trump administration aims to shrink the size of the federal ...

On Jan. 29, independent journalist Ken Klippenstein shared an image on X, formerly Twitter, that appeared to show an internal ...

9M’24 FY’25 guidance revised: revenue expected to decrease by high single digit year-on-year at constant exchange rates and perimeter (compared to flat previously), and EBITDA 1 margin 2 ...

On Jan. 29, independent journalist Ken Klippenstein shared an image on X, formerly Twitter, that appeared to show an internal Defense Intelligence Agency (DIA) memo advising staff the agency will ...

Reaching €226m, Q3’25 revenue was almost stable vs. Q2’25 and down 10% at constant exchange rates and perimeter compared with Q3’24 9M’25 revenue reached €564m, down 12% on a reported basis and ...

InVitro International, Inc., headquartered in Placentia, California, was founded in 1985 and is a customer and technology-driven provider of non-animal testing methods. The Company's testing ...

Reflecting the impact of the change in timing of new business projects in Q4’25, Orion has reduced its FY’25 revenue outlook to a range of $77M – $83M. This outlook implies Q4’25 revenue ...